Clinical Trials Browser

Phase 2 × Serotonin Syndrome × Magnetic Resonance Spectroscopy × Clear all

NCT03453489 2025-04-10

AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm

Phase 2 Completed

4 enrolled 7 charts

Serotonin Syndrome